Avanir Aktie - AVN

12% Strides Linked TO Apple, Inc. (AVN) Aktie

Professionelle Tools für Privatanleger.

Premium

Current Price

( - )

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

Avanti Communications Group Plc 21 December 2009 ? Date: 21 December 2009 On behalf of: Avanti Communications Group plc ("Avanti", "the Group...

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

NEW YORK, Aug. 29 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Merrill Lynch's 12% Callable STRIDES Linked...

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN BOARD: CLSC) , a pharmaceutical development company...

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

The previously announced one-for-four reverse split by AVANIR Pharmaceuticals (AMEX:AVN) of its common stock has become effective, with post-split...

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals (AMEX:AVN) announced today that it has signed an exclusive agreement with a leading importer and distributor of...

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR Pharmaceuticals (AMEX:AVN) announced today that Randall E. Kaye, M.D. has joined the company in the newly created role of Vice President of...

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals (AMEX: AVN) announced today that its Board of Directors has approved the implementation of a one-for-four reverse split of...

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

AVANIR Pharmaceuticals (AMEX:AVN) will be presenting at the 24th Annual JPMorgan Healthcare Conference on Wednesday, January 11, 2005, at 4:00...

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals (AMEX:AVN) announced today that a Phase I study has been initiated in partnership with AstraZeneca UK Limited (AstraZeneca...

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVANIR Pharmaceuticals (AMEX: AVN) announced today that its presentation at the Lazard Capital Markets Annual Life Sciences Conference in New...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AVN - Frequently Asked Questions (FAQ)

What is the current 12% Strides Linked TO Apple, Inc. share price?

The current share price of 12% Strides Linked TO Apple, Inc. is US$ 0,00

What is the 1 year trading range for 12% Strides Linked TO Apple, Inc. share price?

12% Strides Linked TO Apple, Inc. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

12% Strides Linked TO Apple, Inc. (AVN)

12% Strides Linked TO Apple, Inc. (AVN) Aktie

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

AVN Neueste Nachrichten

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVN - Frequently Asked Questions (FAQ)

AVN Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

12% Strides Linked TO Apple, Inc. (AVN)

12% Strides Linked TO Apple, Inc. (AVN) Aktie

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

AVN Neueste Nachrichten

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVN - Frequently Asked Questions (FAQ)

AVN Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Warum ADVFN beitreten?

Alles, was seriöse Trader brauchen.

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE